Drug Profile
HIVEX 01
Alternative Names: HIVEX-01Latest Information Update: 21 Sep 2023
Price :
$50
*
At a glance
- Originator Celdara Medical
- Class Antiretrovirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 21 Sep 2023 Discontinued - Preclinical for HIV-1 infections in USA (unspecified route) prior to September 2023 (Celdara Medical pipeline, September 2023)
- 28 Aug 2020 No recent reports of development identified for preclinical development in HIV-1-infections in USA
- 29 Jul 2016 Preclinical trials in HIV-1 infections in USA (unspecified route)